BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 29533182)

  • 1. Replication Study:
    Repass J;
    Elife; 2018 Mar; 7():. PubMed ID: 29533182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Registered report: Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma.
    Repass J; Maherali N; Owen K; ;
    Elife; 2016 Feb; 5():. PubMed ID: 26882501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Fusobacterium nucleatum, Pathway Mutation, and Patient Prognosis in Colorectal Cancer.
    Lee DW; Han SW; Kang JK; Bae JM; Kim HP; Won JK; Jeong SY; Park KJ; Kang GH; Kim TY
    Ann Surg Oncol; 2018 Oct; 25(11):3389-3395. PubMed ID: 30062471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fusobacterium nucleatum as a prognostic marker of colorectal cancer in a Japanese population.
    Yamaoka Y; Suehiro Y; Hashimoto S; Hoshida T; Fujimoto M; Watanabe M; Imanaga D; Sakai K; Matsumoto T; Nishioka M; Takami T; Suzuki N; Hazama S; Nagano H; Sakaida I; Yamasaki T
    J Gastroenterol; 2018 Apr; 53(4):517-524. PubMed ID: 28823057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between
    Proença MA; Biselli JM; Succi M; Severino FE; Berardinelli GN; Caetano A; Reis RM; Hughes DJ; Silva AE
    World J Gastroenterol; 2018 Dec; 24(47):5351-5365. PubMed ID: 30598580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of microRNA-4474/4717 expression and CREB-binding protein in human colorectal cancer tissues infected with Fusobacterium nucleatum.
    Feng YY; Zeng DZ; Tong YN; Lu XX; Dun GD; Tang B; Zhang ZJ; Ye XL; Li Q; Xie JP; Mao XH
    PLoS One; 2019; 14(4):e0215088. PubMed ID: 30951563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Fusobacterium nucleatum with clinical and molecular features in colorectal serrated pathway.
    Ito M; Kanno S; Nosho K; Sukawa Y; Mitsuhashi K; Kurihara H; Igarashi H; Takahashi T; Tachibana M; Takahashi H; Yoshii S; Takenouchi T; Hasegawa T; Okita K; Hirata K; Maruyama R; Suzuki H; Imai K; Yamamoto H; Shinomura Y
    Int J Cancer; 2015 Sep; 137(6):1258-68. PubMed ID: 25703934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.
    Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y
    Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Hussan H; Clinton SK; Roberts K; Bailey MT
    World J Gastroenterol; 2017 Dec; 23(48):8626-8650. PubMed ID: 29358871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Fusobacterium nucleatum infection with colorectal cancer in Chinese patients.
    Li YY; Ge QX; Cao J; Zhou YJ; Du YL; Shen B; Wan YJ; Nie YQ
    World J Gastroenterol; 2016 Mar; 22(11):3227-33. PubMed ID: 27004000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fusobacterium Nucleatum Is a Risk Factor for Metastatic Colorectal Cancer.
    Chen WD; Zhang X; Zhang YP; Yue CB; Wang YL; Pan HW; Zhang YL; Liu H; Zhang Y
    Curr Med Sci; 2022 Jun; 42(3):538-547. PubMed ID: 35678912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fusobacterium nucleatum in biopsied tissues from colorectal cancer patients and alcohol consumption in Korea.
    Kim M; Lee ST; Choi S; Lee H; Kwon SS; Byun JH; Kim YA; Rhee KJ; Choi JR; Kim TI; Lee K
    Sci Rep; 2020 Nov; 10(1):19915. PubMed ID: 33199749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly sensitive stool DNA testing of Fusobacterium nucleatum as a marker for detection of colorectal tumours in a Japanese population.
    Suehiro Y; Sakai K; Nishioka M; Hashimoto S; Takami T; Higaki S; Shindo Y; Hazama S; Oka M; Nagano H; Sakaida I; Yamasaki T
    Ann Clin Biochem; 2017 Jan; 54(1):86-91. PubMed ID: 27126270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer.
    Nosho K; Sukawa Y; Adachi Y; Ito M; Mitsuhashi K; Kurihara H; Kanno S; Yamamoto I; Ishigami K; Igarashi H; Maruyama R; Imai K; Yamamoto H; Shinomura Y
    World J Gastroenterol; 2016 Jan; 22(2):557-66. PubMed ID: 26811607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Berberine may rescue Fusobacterium nucleatum-induced colorectal tumorigenesis by modulating the tumor microenvironment.
    Yu YN; Yu TC; Zhao HJ; Sun TT; Chen HM; Chen HY; An HF; Weng YR; Yu J; Li M; Qin WX; Ma X; Shen N; Hong J; Fang JY
    Oncotarget; 2015 Oct; 6(31):32013-26. PubMed ID: 26397137
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Ye X; Wang R; Bhattacharya R; Boulbes DR; Fan F; Xia L; Adoni H; Ajami NJ; Wong MC; Smith DP; Petrosino JF; Venable S; Qiao W; Baladandayuthapani V; Maru D; Ellis LM
    Cancer Prev Res (Phila); 2017 Jul; 10(7):398-409. PubMed ID: 28483840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of Fusobacterium nucleatum in stool and colonic tissues from Norwegian colorectal cancer patients.
    Tunsjø HS; Gundersen G; Rangnes F; Noone JC; Endres A; Bemanian V
    Eur J Clin Microbiol Infect Dis; 2019 Jul; 38(7):1367-1376. PubMed ID: 31025134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fusobacterium nucleatum is associated with worse prognosis in Lauren's diffuse type gastric cancer patients.
    Boehm ET; Thon C; Kupcinskas J; Steponaitiene R; Skieceviciene J; Canbay A; Malfertheiner P; Link A
    Sci Rep; 2020 Oct; 10(1):16240. PubMed ID: 33004953
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Gethings-Behncke C; Coleman HG; Jordao HWT; Longley DB; Crawford N; Murray LJ; Kunzmann AT
    Cancer Epidemiol Biomarkers Prev; 2020 Mar; 29(3):539-548. PubMed ID: 31915144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fusobacterium nucleatum upregulates MMP7 to promote metastasis-related characteristics of colorectal cancer cell via activating MAPK(JNK)-AP1 axis.
    Ou S; Chen H; Wang H; Ye J; Liu H; Tao Y; Ran S; Mu X; Liu F; Zhu S; Luo K; Guan Z; Jin Y; Huang R; Song Y; Liu SL
    J Transl Med; 2023 Oct; 21(1):704. PubMed ID: 37814323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.